Average Co-Inventor Count = 6.10
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Frosst Canada, Inc. (15 from 212 patents)
2. Merck Frosst Canada & Co. (12 from 80 patents)
3. Merck Sharp + Dohme Corp. (4 from 2,405 patents)
4. Merck Canada Inc. (4 from 40 patents)
5. Axys Pharmaceuticals, Inc. (4 from 40 patents)
6. Merck + Co., Inc. (2 from 4,770 patents)
7. Robert N. Young (0 patent)
8. Jacques Yves Gauthier (0 patent)
9. Robert Zamboni (0 patent)
10. Michel L. Belley (0 patent)
34 patents:
1. 9822107 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
2. 9353066 - Substituted phenyl-Spleen Tyrosine Kinase (Syk) inhibitors
3. 8772336 - Cathepsin cysteine protease inhibitors
4. 8735417 - Aminopyrimidines as Syk inhibitors
5. 8318748 - Cathepsin cysteine protease inhibitors
6. 7973037 - Cathepsin cysteine protease inhibitors
7. 7407959 - Cathepsin cysteine protease inhibitors
8. 7375134 - Cathepsin cysteine protease inhibitors
9. 7312353 - Cathespin cysteine protease inhibitors
10. 7060715 - Substituted pyridines as selective cyclooxygenase-2 inhibitors
11. 6777433 - Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates
12. 6596736 - Substituted pyridines as selective cyclooxygenase-2 inhibitors
13. 6498151 - Aryldifluoromethylphosphonic acids with sulfur-containing substituents as PTP-1B inhibitors
14. 6486141 - Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
15. 6486142 - Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)